Clinical Trial Update: Iron Supplementation and Neurodevelopmental Outcome in ELGANs [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing iron supplementation and its effect on neurodevelopment in extremely low gestational age neonates has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency

Drugs mentioned

• Iron supplementation (Iron)

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Iron-deficiency | Phase 3 | Status: COMPLETED